High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis

Abstract Individuals carrying anti-citrullinated protein antibodies (ACPA) are considered at high risk of developing rheumatoid arthritis (RA). The altered expression of miRNAs contributes to the pathogenesis of RA. We aimed to identify differentially expressed miRNAs in the peripheral blood of ACPA...

Full description

Bibliographic Details
Main Authors: Klára Prajzlerová, Olga Kryštůfková, Petra Hánová, Veronika Horváthová, Monika Gregová, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt, Mária Filková
Format: Article
Language:English
Published: Nature Portfolio 2021-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-84004-3
_version_ 1818996339347816448
author Klára Prajzlerová
Olga Kryštůfková
Petra Hánová
Veronika Horváthová
Monika Gregová
Karel Pavelka
Jiří Vencovský
Ladislav Šenolt
Mária Filková
author_facet Klára Prajzlerová
Olga Kryštůfková
Petra Hánová
Veronika Horváthová
Monika Gregová
Karel Pavelka
Jiří Vencovský
Ladislav Šenolt
Mária Filková
author_sort Klára Prajzlerová
collection DOAJ
description Abstract Individuals carrying anti-citrullinated protein antibodies (ACPA) are considered at high risk of developing rheumatoid arthritis (RA). The altered expression of miRNAs contributes to the pathogenesis of RA. We aimed to identify differentially expressed miRNAs in the peripheral blood of ACPA-positive individuals with arthralgia at risk of RA compared to healthy controls (HC) and to determine their implications in the preclinical phase of RA. A comprehensive analysis of miRNAs revealed the dysregulation of miR-451 in peripheral blood mononuclear cells (PBMC) and plasma from RA-risk individuals. Higher miR-451 expression in PBMC from RA-risk individuals was further validated. Notably, miR-451 was previously shown to regulate CXCL16, a protein involved in RA pathogenesis. The expression of miR-451 in PBMC positively correlated with the CXCL16 mRNA, which could be secondary to the inflammation-induced expression of miR-451. Transfection of monocytes with pre-miR-451 in vitro resulted in the downregulation of CXCL16. Moreover, flow cytometry revealed a lower count of CXCL16-positive monocytes in RA-risk individuals. We propose that the constitutive or inflammation-induced upregulation of miR-451 in PBMC downregulates the expression of CXCL16, reduces the inflammatory milieu and thereby strives to delay the shift from the preclinical phase to the clinical manifestation of RA. This hypothesis warrants further investigation.
first_indexed 2024-12-20T21:28:10Z
format Article
id doaj.art-34a12d51cbab4668bad29802f3f1eafb
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-20T21:28:10Z
publishDate 2021-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-34a12d51cbab4668bad29802f3f1eafb2022-12-21T19:26:07ZengNature PortfolioScientific Reports2045-23222021-02-011111910.1038/s41598-021-84004-3High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritisKlára Prajzlerová0Olga Kryštůfková1Petra Hánová2Veronika Horváthová3Monika Gregová4Karel Pavelka5Jiří Vencovský6Ladislav Šenolt7Mária Filková8Institute of RheumatologyInstitute of RheumatologyInstitute of RheumatologyInstitute of RheumatologyInstitute of RheumatologyInstitute of RheumatologyInstitute of RheumatologyInstitute of RheumatologyInstitute of RheumatologyAbstract Individuals carrying anti-citrullinated protein antibodies (ACPA) are considered at high risk of developing rheumatoid arthritis (RA). The altered expression of miRNAs contributes to the pathogenesis of RA. We aimed to identify differentially expressed miRNAs in the peripheral blood of ACPA-positive individuals with arthralgia at risk of RA compared to healthy controls (HC) and to determine their implications in the preclinical phase of RA. A comprehensive analysis of miRNAs revealed the dysregulation of miR-451 in peripheral blood mononuclear cells (PBMC) and plasma from RA-risk individuals. Higher miR-451 expression in PBMC from RA-risk individuals was further validated. Notably, miR-451 was previously shown to regulate CXCL16, a protein involved in RA pathogenesis. The expression of miR-451 in PBMC positively correlated with the CXCL16 mRNA, which could be secondary to the inflammation-induced expression of miR-451. Transfection of monocytes with pre-miR-451 in vitro resulted in the downregulation of CXCL16. Moreover, flow cytometry revealed a lower count of CXCL16-positive monocytes in RA-risk individuals. We propose that the constitutive or inflammation-induced upregulation of miR-451 in PBMC downregulates the expression of CXCL16, reduces the inflammatory milieu and thereby strives to delay the shift from the preclinical phase to the clinical manifestation of RA. This hypothesis warrants further investigation.https://doi.org/10.1038/s41598-021-84004-3
spellingShingle Klára Prajzlerová
Olga Kryštůfková
Petra Hánová
Veronika Horváthová
Monika Gregová
Karel Pavelka
Jiří Vencovský
Ladislav Šenolt
Mária Filková
High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis
Scientific Reports
title High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis
title_full High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis
title_fullStr High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis
title_full_unstemmed High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis
title_short High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis
title_sort high mir 451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis
url https://doi.org/10.1038/s41598-021-84004-3
work_keys_str_mv AT klaraprajzlerova highmir451expressioninperipheralbloodmononuclearcellsfromsubjectsatriskofdevelopingrheumatoidarthritis
AT olgakrystufkova highmir451expressioninperipheralbloodmononuclearcellsfromsubjectsatriskofdevelopingrheumatoidarthritis
AT petrahanova highmir451expressioninperipheralbloodmononuclearcellsfromsubjectsatriskofdevelopingrheumatoidarthritis
AT veronikahorvathova highmir451expressioninperipheralbloodmononuclearcellsfromsubjectsatriskofdevelopingrheumatoidarthritis
AT monikagregova highmir451expressioninperipheralbloodmononuclearcellsfromsubjectsatriskofdevelopingrheumatoidarthritis
AT karelpavelka highmir451expressioninperipheralbloodmononuclearcellsfromsubjectsatriskofdevelopingrheumatoidarthritis
AT jirivencovsky highmir451expressioninperipheralbloodmononuclearcellsfromsubjectsatriskofdevelopingrheumatoidarthritis
AT ladislavsenolt highmir451expressioninperipheralbloodmononuclearcellsfromsubjectsatriskofdevelopingrheumatoidarthritis
AT mariafilkova highmir451expressioninperipheralbloodmononuclearcellsfromsubjectsatriskofdevelopingrheumatoidarthritis